Is mavacamten superior to aficamten for hypertrophic cardiomyopathy? A frequentist network meta-analysis
Background: Myosin inhibitors have been shown to improve exercise capacity and symptoms, as well as reduce the left ventricular outflow tract (LVOT) gradient. This study explores the efficacy of mavacamten versus aficamten in hypertrophic cardiomyopathy (HCM) patients. Methods: From the inception to...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Open Exploration Publishing Inc.
2026-01-01
|
| シリーズ: | Exploration of Cardiology |
| 主題: | |
| オンライン･アクセス: | https://www.explorationpub.com/uploads/Article/A101289/101289.pdf |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|